Topics:
Gastrointestinal Cancers • Pediatric Oncology • Medical Oncology • Liver and Pancreas Tumors • NCI-CCC Tumor Board Question • University of Wisconsin • AYA • NCI-CCC GI Tumor Board Question
How do you choose first or second-line systemic therapy for fibrolamellar hepatocellular carcinoma?
What are there most evidence-based options?
Answer from: Medical Oncologist at Academic Institution
Fibrolamellar carcinoma is histologically unique from hepatocellular carcinoma. The disease is correctly called fibrolamellar carcinoma, and not fibrolamellar hepatocellular carcinoma, or hepatocellular carcinoma fibrolamellar variant. Even though the latter may be permissive if the lack of cirrhosi...
Sign in or Register to read more